Results 91 to 100 of about 9,281 (210)
ABSTRACT Objectives Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease characterized by pathogenic anti‐aquaporin‐4 (AQP4) antibodies. Previous studies have shown increased circulating T follicular helper (cTfh) cells and altered Tfh subset frequencies in NMOSD, but the absolute counts of Tfh subsets remain unclear. We
Takafumi Hosokawa +7 more
wiley +1 more source
Induction of immune tolerance in NMOSD and MOGAD
Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are autoimmune diseases characterized by immune-mediated damage to the central nervous system. Current treatments primarily focus on chronic immunosuppression.
Jorge Correale, Edgar Carnero Contentti
openaire +4 more sources
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a neurological complication of primary Sjögren's syndrome (pSS).Objective: We aimed to explore potential serological differences between pSS patients with and without NMOSD.Methods: There were
Lin Qiao +7 more
doaj +1 more source
Jie Ding,1,* Fu-Ping Chen,1,* Ya-Ying Song,1,* Hong-Yan Li,1 Xi-Wen Ai,1 Yi Chen,1 Lu Han,1 Xia-Jun Zhou,1 De-Sheng Zhu,1 Yang-Tai Guan1,2 1Department of Neurology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai ...
Ding J +9 more
doaj
We previously reported that glucose-regulated protein 78 autoantibodies (GRP78 Ab) cause breakdown of the blood-brain barrier (BBB) in neuromyelitis optica spectrum disorder (NMOSD) patients. Objective of the present study is to identify novel antibodies
Fumitaka Shimizu +7 more
doaj +1 more source
Analysis of soluble interleukin-2 receptor as a prognostic biomarker in NMOSD and MOGAD [PDF]
OBJECTIVE: Soluble interleukin-2 receptor (sIL-2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) pathogenesis ...
Asseyer, Susanna +8 more
core +1 more source
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD
While complement-dependent cytotoxicity (CDC) is a known effector mechanism in aquaporin-4-immunoglobulin (Ig)G-positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD), the role of CDC in myelin oligodendrocyte glycoprotein antibody ...
Ringelstein, M. +17 more
core +1 more source
Neuromyelitis Optica Spectrum Disorder in Latin America: State-of-the-Art and Current Challenges
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease of the central nervous system characterized by severe attacks of optic neuritis, myelitis, and/or area postrema.
Edgar Carnero Contentti +6 more
doaj +1 more source
The purpose of the study was to comparatively analyze optical coherence tomography (OCT) data from patients with neuromyelitis optica (NMOSD) and optic neuritis in multiple sclerosis (MS-ON) to identify structural differences and refine diagnostic ...
A. S.-U. Batchaev +7 more
doaj +1 more source
Background and Objectives: Primary central nervous system (CNS) demyelinating disorders such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and ...
Debarup Das +7 more
doaj +1 more source

